Known as MAGENTA (mechanically active gel-elastomer-nitinol tissue adhesive), the experimental device prevents muscle wasting in animals, the team reports ... the device can also be activated remotely ...

Late-stage trial data for Roche’s drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy.

Muscle wasting was detected in 39 (19.5%) subjects. Patients with muscle wasting had significantly lower values for muscle strength, as well as lower total peak oxygen consumption, lower exercise ...

others experience swift and severe muscle weakness and wasting, dying in their late teens to early 20s. The various types of MD affect more than 50,000 Americans. Through advances in medical care ...

Hundreds of children born with a degenerative muscle-wasting disease are to be offered a new drug on the NHS that can slow the deadly condition’s progression. Duchenne muscular dystrophy (DMD ...

Late-stage trial data for Roche's drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy.